Service d'Anesthésie, Université de Lyon, Marcy l'Etoile, France.
Open Vet J. 2024 Jun;14(6):1483-1490. doi: 10.5455/OVJ.2024.v14.i6.17. Epub 2024 Jun 30.
The anesthetic management of adrenalectomies for phaeochromocytoma excision, a catecholamine-secreting tumor, is challenging due to the potential for fatal complications following severe hemodynamic variations, including hypertensive crisis following tumor manipulation or sympathetic stimulation, but also severe hypotension and volume depletion post resection.
An 11 kg, 15-year-old male neutered Jack Russel Terrier, with mitral valve disease stage B2, was referred for adrenalectomy for phaeochromocytoma resection. The patient was administered per os prazosin 0.11 mg/kg twice a day and amlodipine 0.125 mg/kg once a day for preoperative stabilization. On the day of surgery, the dog received maropitant 1 mg/kg intravenously (IV) and was premedicated with 0.2 mg/kg methadone IV. Anesthesia was induced with alfaxalone 1 mg/kg IV and midazolam 0.2 mg/kg IV and maintained with partial intravenous anesthesia using sevoflurane in 70% oxygen and constant rate infusions of dexmedetomidine 0.5 μg/kg/hour and maropitant 100 μg/kg/hour. After induction of anesthesia, the dog was mechanically ventilated, and a transversus abdominal plane block was performed with ropivacaine 0.2%. The dog remained remarkably stable with a single, self-limiting, hypertension episode recorded intraoperatively. Postoperative rescue analgesia consisted of methadone and ketamine. The dog was discharged 48 hours after surgery, but persistent hypertension was reported at suture removal.
The use of a low-dose dexmedetomidine CRI, a maropitant CRI, and a transversus abdominal plane block provided stable perioperative hemodynamic conditions for phaeochromocytoma excision in a dog.
由于严重的血流动力学变化可能导致致命的并发症,如肿瘤操作或交感神经刺激后的高血压危象,以及切除后严重低血压和容量耗竭,因此嗜铬细胞瘤切除术的麻醉管理具有挑战性。嗜铬细胞瘤是一种儿茶酚胺分泌肿瘤。
一只 11 公斤、15 岁的雄性杰克罗素梗,患有二尖瓣疾病 B2 期,因嗜铬细胞瘤切除术而被转诊行肾上腺切除术。该患者接受了口服普萘洛尔 0.11 毫克/千克,每天两次,以及氨氯地平 0.125 毫克/千克,每天一次,以进行术前稳定。手术当天,该犬接受了马罗替坦 1 毫克/千克静脉注射(IV),并接受了 0.2 毫克/千克吗啡 IV 预处理。麻醉诱导使用阿法沙龙 1 毫克/千克 IV 和咪达唑仑 0.2 毫克/千克 IV,并使用 70%氧气中的七氟醚维持部分静脉麻醉,同时持续输注右美托咪定 0.5 微克/千克/小时和马罗替坦 100 微克/千克/小时。麻醉诱导后,该犬进行机械通气,并进行了罗哌卡因 0.2%的腹横平面阻滞。该犬在术中仅记录到一次自行缓解的高血压发作,但仍保持显著稳定。术后解救镇痛包括吗啡和氯胺酮。该犬在手术后 48 小时出院,但在拆线时仍报告持续性高血压。
在一只犬的嗜铬细胞瘤切除术中,使用低剂量右美托咪定 CRI、马罗替坦 CRI 和腹横平面阻滞,为围手术期提供了稳定的血流动力学条件。